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Method
The clinical histories of and biopsy specimens from 108 patients with prostatic adenocarcinoma were studied to assess the following parameters: clinical and pathological stage; histological pattern (VACURG score) and nuclear anaplasia grade (NG); tumoural necrosis; and stromal in¯ammatory response. Tumoural ploidy and proliferation rate studies were performed using¯ow cytometry. The presence of the anti-p53 antibody was immunohistochemically analysed using the peroxidase±antiperoxidase method. Follow-up was from 3 to 10 y.
Results
Some degree of concordance between the clinical/pathological stages and VACURG score and nuclear anaplasia grade was demonstrated. In stage A, no cases were nuclear anaplasia grade 3 (75% were grade 1), whereas in stage D almost 50% were nuclear anaplasia grade 3. In stage A, only one case had a VACURG score of 7, whereas in stage D 50% presented with a VACURG score b 7. Tumoural necrosis (focal or diffuse) was associated with high nuclear grades and scores (adverse prognostic parameters) and lower survival indexes. No correlation was found between the intensity of in¯ammatory response in the tumoural stroma and the nuclear anaplasia grade or VACURG score. In 82 cases, it was possible to assess DNA ploidy (76.8% were diploid and 23.17% aneuploid). Aneuploidy was more common in stage D and systematic in moderate or poorly differentiated adenocarcinomas (VACURG scores 6). All tumours with VACURG scores 6 were diploid. The mortality rate in patients with aneuploid tumours was higher than in patients with diploid tumours. Proliferation rates in aneuploid tumours were sensitively high ( b 15%). Diploid tumours with proliferation rates b 10% were associated with high nuclear anaplasia grades, whereas no diploid tumours with proliferation rates`10% presented with a nuclear anaplasia grade 3. The immunohistochemical expression study of protein p53 could only be performed on 35 subjects. Of these, 10 (28.5%) expressed a relevant positive immunostaining for p53. The positivity of p53 in low VACURG score was approximately 12%, compared with 44.5% in high VACURG scores (7±10). The p53 expression was related to high nuclear grades (2±3), as no cases which were nuclear anaplasia grade 1 showed p53 positivity. Tumoural necrosis was associated with a higher incidence in the protein p53 expression. There was no correlation between tumoural ploidy and p53 positive immunohistochemical expression. However, there was no relationship between low tumoural proliferation rates (percentage of cells in phase S`10%) and positive expression of p53.
Conclusion
The fundamental factors determining patient survival found in this study are tumoural stage and necrosis, which were in turn correlated with nuclear anaplasia grade and VACURG score. The aneuploidy percentage was very low, and non-existent in cases with low VACURG scores. Proliferation rates in aneuploid tumours were sensitively high ( b 15%). In our study, protein p53 immunohistochemical overexpression was moderately high (28.5%) and associated with nuclear anaplasia grade, VACURG score and the presence of tumoural necrosis. There was no correlation between p53 positivity and ploidy, although the former correlated with high proliferation rates (percentage cells in phase S b 10%).
